ZTEK
ZentekZTEK
ZTEK
About: Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
Employees: 25
0
Funds holding %
of 6,823 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
0.43% more ownership
Funds ownership: 1.03% [Q2] → 1.46% (+0.43%) [Q3]
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
3% less capital invested
Capital invested by funds: $1.14M [Q2] → $1.11M (-$36.5K) [Q3]
12% less funds holding
Funds holding: 17 [Q2] → 15 (-2) [Q3]
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Research analyst outlook
We haven’t received any recent analyst ratings for ZTEK.
Financial journalist opinion
Neutral
Accesswire
3 days ago
Zentek Provides Update on ZenGUARD(TM) Enhanced Air Filters for the Canadian Market
GUELPH, ON / ACCESS Newswire / January 17, 2025 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, is pleased to provide an update on the launch of ZenGUARD™ Enhanced Air Filters in the Canadian Market.
Neutral
Accesswire
1 week ago
Zentek Subsidiary Albany Graphite Corp. Simplifies Process to Achieve Five Nines Purity
GUELPH, ON / ACCESSWIRE / January 8, 2025 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company is pleased to announce that its wholly owned subsidiary, Albany Graphite Corporation (AGC) has achieved a preliminary five-nines purity of 99.9991% directly from a larger Albany graphite deposit flotation concentrate sample utilizing an operational pilot-scale fluidized bed reactor (FBR).
Neutral
Accesswire
1 month ago
Zentek Provides Update on International Opportunities
GUELPH, ON / ACCESSWIRE / December 12, 2024 / Zentek Ltd. (" Zentek "or the " Company ") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, has signed a Memorandum of Understanding ("MOU") with Al-Ramez International Group - through Saudi Excellence Holding Company - establishing a strategic partnership to drive innovation and commercialization in advanced technologies across the Kingdom of Saudi Arabia ("KSA") and the Middle East and North Africa ("MENA") region on November 14 th 2024.
Neutral
Accesswire
1 month ago
Zentek Ltd. Regains Nasdaq Compliance re Minimum Bid Price
GUELPH, ON / ACCESSWIRE / December 9, 2024 / Zentek Ltd. ("Zentek"or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, announces that on December 3, 2024, it received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), as the minimum bid price of the Company's common stock ("Common Stock") has been above US $1.00 per share for the last 11 consecutive business days.
Neutral
Accesswire
1 month ago
ZenGUARD(TM) Enhanced Air Filters to Be Added as Class 1 Medical Device Under Zentek's Medical Device Establishment Licence
GUELPH, ON / ACCESSWIRE / November 27, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, announces its decision that its ZenGUARD™ Enhanced Air Filters will be added under the company's existing medical device establishment licence ("MDEL"), similar to ZenGUARD™ Surgical Masks.
Neutral
Accesswire
2 months ago
Zentek and Triera Biosciences Ltd. Receive $1.1 Million Government of Canada Contract to Test Multivalent Aptamer Technology
GUELPH, ON / ACCESSWIRE / November 6, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), announces that its wholly-owned subsidiary Triera Biosciences Ltd.
Neutral
Accesswire
2 months ago
Zentek Provides Regulatory Update for ZenGUARD(TM) Enhanced Air Filters
GUELPH, ON / ACCESSWIRE / October 31, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company announces that it has withdrawn its submission to the Health Canada Pest Management Regulatory Agency ("PMRA") for its ZenGUARD™ Enhanced Air Filters.
Neutral
Accesswire
3 months ago
Zentek Provides Market Update on ZenGUARD(TM) Antimicrobial Surgical Masks
GUELPH, ON / ACCESSWIRE / October 17, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, is pleased to provide an update on recent commercialization activities for its ZenGUARD™Antimicrobial Surgical Masks.
Neutral
Newsfile Corp
3 months ago
Zentek Announces Voting Results of Annual and Special Meeting
Guelph, Ontario--(Newsfile Corp. - September 26, 2024) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company"), an intellectual property development and commercialization company, announces the voting results from its annual and special meeting of shareholders (the "Meeting") held on September 26, 2024.
Neutral
Newsfile Corp
4 months ago
Zentek Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Guelph, Ontario--(Newsfile Corp. - September 13, 2024) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company") announces that on September 11, 2024, it received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), as the minimum bid price of the Company's common shares ("Shares") has been below US $1.00 per share for 31 consecutive business days.
Charts implemented using Lightweight Charts™